— No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study
OSAKA, Japan, Aug. 29, 2014 /PRNewswire/ — Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the …
Read More— Company To Pursue Next Stage of Development
REDWOOD CITY, California, Aug. 15, 2014 /PRNewswire/ — Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a pivotal clinical pharmacokinetic …
Read MoreDARMSTADT, Germany, July 29, 2014 /PRNewswire/ —
TEANECK, N.J., July 24, 2014 /PRNewswire/ — Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will …
Read MoreWINNIPEG, Manitoba, July 24, 2014 /PRNewswire/ — Canola oil can help control blood glucose (blood sugar) in people with type 2 diabetes when included as part of a low-glycemic index (GI) diet, according to research presented at the June …
Read MorePHILADELPHIA, July 22, 2014 /PRNewswire/ — The Intellectual Property and Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, today announced Cortellis Clinical Trials Intelligence, its global clinical-drug-trial intelligence database, …
Read MoreCAMBRIDGE, Mass., July 22, 2014 /PRNewswire/ — As part of a multinational, collaborative effort, researchers from the Broad Institute, Massachusetts General Hospital (MGH), and scores of other institutions from all over the world have helped identify over 100 locations in …
Read MoreREDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ — Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept (Enbrel®), in chronic plaque psoriasis (the RaPsOdy trial). This announcement …
Read More